Gene-Directed Programmed Cell Death

Gene Oriented Program Programmed cell death including cell death, apoptosis is gene-oriented. Jonathan C. Busser, researcher of neurology and neurosurgery at Case Western reserve University School of Medicine, says: "Leaving from" and "Sagging" means "falling out of". Explanation of natural, inflammatory proliferative cells dies as part of normal development.

Description: TECHNICAL FIELD The present invention relates to a cell death gene which is a gene required for programmed cell death, a mutant organism, a cell death gene having a programmed cell death rate lower than usual, a cell death gene product An antibody that binds, and an antibody that binds to a cell death gene product. An agent that alters the ability of a cell death gene to cause programmed cell death. As described herein, Applicants have identified two genes that play a role in initiating apoptosis or programmed cell death. These two genes, called Reaper (rpr) gene and head degeneration defect (hid) gene, respectively, are located at position 75 C 1, 2 on chromosome 3 of Drosophila melanogaster (D) and are detailed below. Write it as described. Expression pattern associated with cell death analysis pattern during development of Drosophila embryo; mutation of each gene reduces cell death level or eliminates cell death

Since it avoids the order of the cell cycle, it is known to regulate or program cell death time. These genes are called tumor suppressor signaling pathways involved in programmed cell death called apoptosis.

b) Tumor suppressor gene - "off" switch. Tumor suppressor genes are normal genes (processes called apoptosis or programmed cell death) that slow down cell division, repair DNA errors, and communicate to cells when the cell dies. If the tumor suppressor gene is not functioning properly, the cell loses control and causes cancer. This is why cancer has continued to stay with us since the beginning of humanity and may last forever with us until the end of humanity. It also explains the almost uncompromising challenge of cancer treatment. How do you define such targeted therapies and specific therapies to control the growth of cancer cells without killing normal cells?